Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress
CoronaStress
1 other identifier
interventional
120
1 country
1
Brief Summary
The current study examines an adapted guided self-help stress reduction program, focusing on reducing stress in the time of COVID-19. Two studies are planned: 1) an international study in English in which individuals proficient in English throughout the world will participate and 2) a follow-up study in Hebrew.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2020
CompletedStudy Start
First participant enrolled
May 14, 2020
CompletedFirst Posted
Study publicly available on registry
May 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFebruary 9, 2021
February 1, 2021
1.6 years
May 13, 2020
February 8, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
The CoRonavIruS Health Impact Survey (CRISIS)
change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic.
change from Pre to post treatment (6 weeks),
The CoRonavIruS Health Impact Survey (CRISIS)
change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic.
change from Pre to 6 months Follow-up
The CoRonavIruS Health Impact Survey (CRISIS)
change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic.
change from Pre to 1 year Follow-up
Secondary Outcomes (3)
Depression, Anxiety, and Stress Scale- 21 item version: DASS-21
Weekly change during treatment and at pre and post (6 week) treatment evaluations
Depression, Anxiety, and Stress Scale- 21 item version: DASS-21
change from pre to 6 month follow up
Depression, Anxiety, and Stress Scale- 21 item version: DASS-21
change from pre to 1 year follow-up
Other Outcomes (1)
completion rate of modules
6 weeks
Study Arms (2)
immediate guided self-help
EXPERIMENTALIn this condition, individuals will be given access to material and exercises based on CBT to reduce their stress
waitlist
NO INTERVENTIONIndividuals in this condition will wait 6 weeks before they are provided access to the guided self-help program
Interventions
Individuals are provided basic rationale of CBT to deal with stress, worry, anxiety, dysphoria, sleep difficulties, emotion dysregulation, and memories all related to COVID-19
Eligibility Criteria
You may qualify if:
- Read/Write English,
- feels stress due to Corona/COVID-19
You may not qualify if:
- current psychological or psychiatric treatment,
- current psychiatric illness,
- suicidality,
- psychosis,
- bipolar,
- severe dissociative symptoms,
- in a currently severe traumatic situation,
- having a serious medical illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hebrew University of Jerusalem
Jerusalem, 9190501, Israel
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 13, 2020
First Posted
May 19, 2020
Study Start
May 14, 2020
Primary Completion
December 31, 2021
Study Completion
June 30, 2022
Last Updated
February 9, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share